<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03734666</url>
  </required_header>
  <id_info>
    <org_study_id>MCC-19630</org_study_id>
    <secondary_id>R34AT009689</secondary_id>
    <nct_id>NCT03734666</nct_id>
  </id_info>
  <brief_title>Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation</brief_title>
  <official_title>Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lee Moffitt Cancer Center and Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>H. Lee Moffitt Cancer Center and Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop a treatment that can effectively help people reduce&#xD;
      their alcohol use and quit smoking.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study evaluates a mindfulness-based treatment to concurrently target cigarette smoking&#xD;
      and alcohol use behaviors in adults.&#xD;
&#xD;
      Aim 1: Modify an existing mindfulness-based treatment to include a focus on smoking cessation&#xD;
      and reduced alcohol use.&#xD;
&#xD;
      Aim 2: Evaluate benchmarks regarding the feasibility and acceptability of Mindfulness Based&#xD;
      Relapse Prevention -Smoking and Alcohol Use.&#xD;
&#xD;
      Aim 3: Collect and examine descriptive data on proximal and distal variables associated with&#xD;
      increased smoking abstinence and reduced drinking.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 14, 2019</start_date>
  <completion_date type="Anticipated">November 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aim 2: Participant Satisfaction</measure>
    <time_frame>End of treatment (Week 21)</time_frame>
    <description>Patient satisfaction will be determined through a score on the Client Satisfaction Questionnaire Version 8 (Attkinson &amp; Greenfield), where participants respond to 8 items on a 4-point scale (1=very dissatisfied; 4=very satisfied).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aim 2: Rate of Recruitment</measure>
    <time_frame>End of recruitment, Year 3</time_frame>
    <description>Rate of recruitment per month</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aim 2: Participant Retention</measure>
    <time_frame>End of study, Year 3</time_frame>
    <description>Number of participants retained through follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aim 2: Questionnaire Completion</measure>
    <time_frame>End of study, Year 3</time_frame>
    <description>Percentage of questionnaires completed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aim 3: Rate of Smoking Abstinence</measure>
    <time_frame>End of treatment, 16 week follow-up</time_frame>
    <description>Rate of smoking abstinence, measured by biochemical verification of abstinence via saliva continine and self-report of no smoking in the past 7 days. Participants who report abstinence will be mailed a saliva continine kit to confirm abstinence at their 16 week follow up call.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aim 3: Rate of Alcohol Use</measure>
    <time_frame>End of treatment, 16 week follow-up</time_frame>
    <description>Rate of Alcohol use, measured by self-report of no alcohol consumption in the past 7 days at end of study.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Tobacco Use</condition>
  <condition>Alcohol Use, Unspecified</condition>
  <arm_group>
    <arm_group_label>Mindfulness Based Relapse Prevention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive Mindfulness Based Relapse Prevention (MBRP), an existing substance use treatment, which has been modified to focus explicitly on smoking cessation and reduced alcohol use, creating Mindfulness Based Relapse Prevention - Smoking and Alcohol (MBRP-SA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive Cognitive Behavioral Therapy (CBT) a well-established and commonly used treatment for substance abuse behaviors that utilizes problem solving and coping skills.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness Based Relapse Prevention - Smoking and Alcohol</intervention_name>
    <description>Mindfulness Based Relapse Prevention (MBRP) is a treatment for preventing relapse in addictive disorders that integrates mindfulness meditation with standard relapse prevention practices.</description>
    <arm_group_label>Mindfulness Based Relapse Prevention</arm_group_label>
    <other_name>MBRP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <description>Cognitive Behavioral Therapy (CBT) is a form of therapy that aims to help individuals modify problematic emotions, behaviors, and thoughts.</description>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
    <other_name>CBT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria Aim 1:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Currently smoking 3 or more cigarettes per day for the past year.&#xD;
&#xD;
          -  Carbon monoxide level &gt;/= 8 ppm(parts per million); should carbon monoxide level yield&#xD;
             a result less than 8 ppm, participant will be asked to submit a urine sample to&#xD;
             determine contine levels and the result must be &gt;/ level 3&#xD;
&#xD;
          -  Participant must be motivated to quit smoking and decrease alcohol use within the next&#xD;
             60 days&#xD;
&#xD;
          -  If male, consume &gt;/= 5 drinks and if female consume &gt;/= 4 drinks on at least 1&#xD;
             occasion in the past month&#xD;
&#xD;
          -  Willing and able to attend the 8 weekly group sessions&#xD;
&#xD;
          -  Valid home address in the Tampa Bay area&#xD;
&#xD;
          -  Functioning telephone number&#xD;
&#xD;
          -  Can speak, read and write in English&#xD;
&#xD;
        Inclusion Criteria Aim 2:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Currently smoking 3 or more cigarettes per day for the past year.&#xD;
&#xD;
          -  Motivated to quit smoking and decrease alcohol use within the next 60 days&#xD;
&#xD;
          -  If male, consumes &gt;/= 5 drinks and if female consumes &gt;/= 4 drinks on at least 1&#xD;
             occasion in the past month&#xD;
&#xD;
          -  Willingness and ability to attend 8 weekly video group sessions&#xD;
&#xD;
          -  Willingness and ability to use an email account for study materials&#xD;
&#xD;
          -  Valid address&#xD;
&#xD;
          -  Functioning telephone number&#xD;
&#xD;
          -  Can speak, read and write in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to wear nicotine patch&#xD;
&#xD;
          -  Participants who have an active substance use disorder other than an alcohol use&#xD;
             disorder&#xD;
&#xD;
          -  Participants who have an active psychotic disorder&#xD;
&#xD;
          -  Current use of tobacco cessation medications&#xD;
&#xD;
          -  Pregnant or nursing&#xD;
&#xD;
          -  Participants who have a household member already enrolled in the study.&#xD;
&#xD;
          -  In rare cases, study staff might exclude a participant for a reason not specified here&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine Vinci, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>H. Lee Moffitt Cancer Center and Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>H Lee Moffitt Cancer Center and Research Institute</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://moffitt.org/clinical-trials-research/clinical-trials/</url>
    <description>Moffitt Cancer Center Clinical Trials Website</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 5, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2018</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>alcohol drinking</keyword>
  <keyword>quit smoking</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

